The U.S. Food and Drug Administration has cleared 23andMe to sell directly to customers a DNA test for gene mutations linked to breast cancer, making it the first consumer DNA testing company to win the agency’s approval for a cancer risk screening.
Source: Gizmodo – 23andMe Gets FDA Green Light to Sell First Consumer DNA Test for Cancer Risk